Quality-of-Life Outcomes With a Disodium EDTA Chelation Regimen for Coronary Disease: Results From the Trial to Assess Chelation Therapy Randomized Trial [Original Articles]

Conclusions— In stable, predominantly asymptomatic coronary disease patients with a history of myocardial infarction, EDTA chelation therapy did not have a detectable effect on QOL during 2 years of follow-up. Clinical Trial Registration— URL: http://clinicaltrials.gov. Unique identifier: NCT00044213.

http://circoutcomes.ahajournals.org/cgi/content/short/7/4/508?rss=1

Source: Circulation: Cardiovascular Quality and Outcomes - July 15, 2014 Category: Cardiology Authors: Mark, D. B., Anstrom, K. J., Clapp-Channing, N. E., Knight, J. D., Boineau, R., Goertz, C., Rozema, T. C., Liu, D. M., Nahin, R. L., Rosenberg, Y., Drisko, J., Lee, K. L., Lamas, G. A., on behalf of the TACT Investigators Tags: Other Treatment Original Articles Source Type: research